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Abstract
Acquired immunity against helminths is characterised by a complex interplay between the effector Th1 and Th2 immune
responses and it slowly manifests with age as a result of cumulative exposure to parasite antigens. Data from experimental
models suggest that immunity is also influenced by regulatory T cells (Treg), but as yet studies on Treg in human
schistosome infections are limited. This study investigated the relationship between schistosome infection intensity and
the two cell populations regulatory T cells (Treg: CD4
+(dim)CD25
+(high)FOXP3
+CD127
low), and activated (Tact:
CD4
+CD25
+FOXP3
2) T cells in Zimbabweans exposed to Schistosoma haematobium parasites. Participants were partitioned
into two age groups, young children (8–13 years) in whom schistosome infection levels were rising to peak and older
people (14+ years) with declining infection levels. The relationship between Tact proportions and schistosome infection
intensity remained unchanged with age. However Treg proportions rose significantly with increasing infection in the
younger age group. In contrast Treg were negatively correlated to infection intensity in the older age group. The relative
proportions of regulatory T cells differ significantly between young individuals in whom high infection is associated with an
enhanced regulatory phenotype and older infected patients in whom the regulatory response is attenuated. This may
influence or reflect different stages of the development of protective schistosome acquired immunity and
immunopathogenesis.
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Introduction
Schistosomiasis is a major human parasitic disease caused by
different species of trematode parasites of the genus Schistosoma.
Urogenital schistosomiasis caused by S. haematobium is the most
prevalent form in sub-Saharan Africa where it is associated with
pathology ranging from hematuria to more severe conditions such
as hydronephrosis and bladder cancer [1].
The role of acquired immunity in reducing human schistosome
infection intensity and pathology has been subject to intense study
[2,3,4]. Early studies suggested that anti-schistosome immune
responses fell into a clear Th1/Th2 dichotomy with resistance to
infection being associated with Th2 responses [5,6], but mounting
evidence shows this dichotomy cannot adequately explain the
balance between susceptibility and resistance to infection [7,8].
For example, we have previously shown that neither Th1 nor Th2
cytokine responses in S. haematobium-infected Zimbabwean children
show a clear pattern with infection intensity [9,10] supporting
similar reports on S. manosni vaccine candidates [11] and other
immuno-epidemiology studies (reviewed in [12,13]).
The discovery that a regulatory subset of CD4
+ T cells (Treg)
modulates the activity of effector Th1 and Th2 responses in mouse
models of schistosomiasis [14] has led to suggestions that it is the
balance between effector and regulatory responses including Treg,
which determines the outcome of murine helminth infections [15],
has also been postulated for human helminth infections [16,17].
This concept is not unique to helminth infections; regulatory T
cells have been invoked across a wide range of infectious diseases
including fungal, bacterial and viral infections [18,19,20,21,22]
and non infectious diseases such as allergies or cancer [23,24], and
modulation of immunopathology by regulatory T cells has been
reported in human and mouse models [25,26,27,28].
There have been several studies of the phenotype and role of
Treg cells in mouse models of helminth infections [15,29,30,31]
including schistosomiasis [27,32,33,34], but to date there is a
paucity of studies of human Treg responses in helminth infections.
Human Treg were initially identified as those expressing the
highest levels of CD25 [35], and using this marker it was reported
that regulatory and effector cells show an inverse relationship in
schistosomiasis [36]. In addition a study in Kenyan children found
differences in activated T cells and memory regulatory T cells
between individuals with S. mansoni only compared to individuals
concurrently infected with S. mansoni and Plasmodium falciparum
[37].
The discovery of the forkhead/winged helix transcription factor
FOXP3 as a marker for these cells allows a more accurate
characterization of Treg [38,39,40]. Some studies suggested that
human FOXP3
+ cells (in contrast to mouse FoxP3
+ Treg) are
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FOXP3 on activated T cells does not correlate with suppressive
function [42]. However FOXP3 is still considered the most
accurate marker for naturally occurring Treg [43]. Recent studies
have further characterized the phenotype of Treg by the
expression of low levels of CD127 [44] and slightly diminished
levels of CD4 [45]. By using a combination of these markers we
have investigated the relationship between Treg, effector T cells
and schistosome infection intensity. The aim of the study was to
determine if the percentage of activated T cells (Tact, defined as
CD4
+CD25
+FOXP3
2) or regulatory T cells (Treg, defined as
CD4
+CD25
+(high)FOXP3
+CD127
dim) differed with schistosome
infection intensity.
Materials and Methods
Ethics Statement
Permission to conduct the study in the region was obtained from
the Provincial Medical Director and institutional and ethical
approval was received from the University of Zimbabwe’s Institute
Review Board (UZIRB) and the Medical Research Council of
Zimbabwe (MRCZ) respectively. Only compliant participants
were recruited into the study and they were free to drop out at any
point during the study. At the beginning of the study, participants
and their parents/guardians had the aims and procedures of the
project explained fully in the local language, Shona, and oral
consent was obtained from participants and parents/guardian
before parasitology and blood samples were obtained. Oral
informed consent was obtained because of the high levels of
illiteracy and cultural reasons [46]. Both the UZIRB and MRZC
approved the use of oral consent. Upon oral consent participants
were enrolled in the study with a written record of their name, age,
sex and case number, this served as both the record of oral consent
and enrolment record.
Study population and parasitology
The study was conducted in the Mashonaland East Province of
Zimbabwe (31
o309E; 17
o459S) where S. haematobium is endemic and
where the participants have been participating in an ongoing study
of the immuno-epidemiology of human schistosomiasis [47,48].
The villages were selected because health surveys regularly
conducted in the region showed little or no infection with other
helminths and a low S. mansoni prevalence (,5%) [49,50]. The two
villages selected (Goromonzi and Mutoko) had not been included
in the National Schistosome Control Programme and therefore
participants had not received antihelminthic treatment for
schistosomiasis or other helminth infections meaning that their
natural immune responses could be studied in the absence of drug-
altered schistosome responses [51]. The main activity in these
villages is subsistence farming and human water contact is frequent
with at least 4 contacts/person/week (assessed by questionnaire,
adapted from [52,53]) due to insufficient safe water and sanitation
facilities. Drinking water is collected from open wells while bathing
and washing is conducted in two main rivers in the villages. The
schools surveyed in the two villages were all in close proximity to
rivers.
Helminth infection intensity was assessed by microscopic
examination of urine and stool samples. Urine specimens were
processed by urine filtration following a standard method
originally described by Mott et al. [54] for diagnosis of S.
haematobium. Fresh stool specimens were processed by the Kato-
Katz technique and subsequently analysed by microscopy for
intestinal helminths including S. mansoni, hookworm, Ascaris
lumbricoides and Trichuris trichiura. The formol-ether concentration
method was performed on 50% of the samples to confirm results
obtained by the Kato-Katz technique [55]. Stool and urine
specimens were collected on three consecutive days.
In order to be included in the cohort, participants had to meet
all the following criteria which are comparable to other studies
performed for human Schistosomiasis [36,56,57]: 1) be life-long
residents of the schistosome-endemic area; 2) not have received
prior treatment for helminth infections; 3) have provided at least 2
urine and 2 stool samples on consecutive days; 4) be negative for
intestinal helminths including S. mansoni and negative for
Plasmodium parasites as determined by blood smears; 5) have given
a blood sample for the collection of peripheral blood mononuclear
cells (PBMC). Forty-nine participants aged 8–60 years met these
criteria and formed our study population. Questionnaire studies
indicated that there were no significant differences in water
contact measures (frequency or duration) between the age groups.
After collection of all samples, all participants were offered
treatment with the recommended dose of praziquantel (40 mg/kg
of body weight).
Collection of PBMC
Twenty millilitres of venous blood was collected in heparinised
tubes of which 5 ml was used for serological assays as well as
microscopic detection of malaria parasites. Fifteen ml were used to
collect peripheral blood mononuclear cells (PBMC) through
density gradient centrifugation using Lymphoprep
TM (Axis-Shield,
Cambridgeshire, UK). These PBMC were subsequently, enumer-
ated, cryo-preserved and stored in liquid nitrogen in Zimbabwe
prior to freighting to Edinburgh in dry shippers for assay.
Phenotyping of PBMC
Thawing of cryopreserved PBMC was performed by rotating
cryovials in a 37uC water bath until a small crystal was remaining
in the cell suspension. Medium (RPMI 1640 supplemented with
10% Fetal bovine serum, 2 mM L-glutamine and 100 U
Penicillin/Streptomycin; all Lonza, Verviers, Belgium) was slowly
added to the PBMC. Cells were washed twice with the
corresponding medium, counted and viability assessed using
trypan blue (Sigma-Aldrich, Dorsert, UK). Afterwards cells were
washed with Dulbecco’s-PBS (Lonza) and surface stained with the
following antibodies: Alexa488-conjugated anti-CD4 (clone OKT-
4), PE-Cy7-conjugated anti-CD127 (clone eBioRDR5; all from
eBiosciences, San Diego, USA), PE-conjugated anti-CD25 (clone
M-A251, BD Biosciences, San Jose, USA). Intracellular staining
was performed using APC-conjugated anti-FOXP3 (clone
PCH101, eBioscience) and the intracellular staining set from
eBioscience following the maufacturer’s instructions. Stained cells
were analysed on a FACSCalibur
TM using CellQuestPro
TM
software (BD Biosciences).
Statistics
In an initial analysis was determined if the proportion of Treg
and Tact relative to the total CD4
+ T cells varied with host age.
This analysis was conducted using a multivariate analysis of
variance (MANOVA) allowing for sex (categorical; male, female),
and residential village (categorical; Goromonzi, Mutoko). T cell
percentage data were arcsine square root transformed to allow the
use of parametric tests [58].
Subsequently the relationship between the proportions of Treg and
Tact relative to total CD4
+ T cells and infection intensity was
determined using an analysis of variance (ANOVA). In this statistical
test, the dependent variable was infection intensity (log 10(x+1)
transformed), and the independent variables were Tact and Treg
transformed as above. The possible confounding variables sex, village
Regulatory T Cells in Human Schistosomiasis
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and age group 2 (14+ years)) were allowed for by using sequential
sums of squares. Following the ANOVA the relationship between the
between the two T cell subsets and the infection intensity was
analysed using residuals for infection intensity (log10(x+1) trans-
formed) after allowing for the effects of sex and village (as before)
using a regression analysis.
A description of these statistical methods has been published
previously by Mutapi and Roddam [59]. All statistical tests were
conducted using the software package SPSS and p values were
taken to be significant at p,0.05.
Results
Schistosome epidemiology of study population
The prevalence of S. haematobium in the analysed population was
78% with a mean egg count of 28 eggs/10 ml urine (SEM=5) with
a range of 0 to 126 eggs/10 ml of urine. The population shows a
typical convex age-infection profile for schistosome infection
intensity, with infection intensity rising in the youngest age group
(8–10 years), peaking in people aged 11–13 years and subsequently
declining above 14 years of age. This infection profile corresponds
to our data published previously for this population [47,48].
Based on this profile the study population was divided into two age
groups. In the first age group (8–13 years, N=30) infection intensity is
rising to peak whereas in the second group (14+,N = 1 9 )i n f e c t i o n
intensity is declining as summarized in Figure 1. Mean infection
intensitywassignificantlyhigher (p=0.01) in the 8–13 year-group (39.4
eggs/10 ml urine 67.3) compared to the 14+ year group (12.7 eggs/
10 ml urine 6 4.9) and there were both egg negative and egg positive
individuals in both groups as shown in Figure 1. The infection
prevalence was significantly higher (x
2=5.16, df=1, p=0.023) in the
younger group compared to the older group at 90% versus 63%
respectively. All participants were negative for Plasmodium parasites as
determined by microscopic examination of blood smears.
Discrimination of regulatory and activated T cells
CD4
+ Treg express a characteristic combination of molecular
markers which distinguish them from activated effector T cells
(Tact), including CD25
high and FOXP3 [38,40]. In addition, Treg
show diminished levels of CD4 [45] and low levels of CD127 [44].
CD4
+ lymphocytes were analyzed for the expression of CD25,
FOXP3 and CD127 (Figure 2A) and gated on either
CD4
+CD25
+FOXP
+ (Treg) or CD4
+CD25
+FOXP
2 (Tact) subsets
(Figure 2B, C). CD25
+FOXP3
+ Treg expressed CD25 at high levels
and showed a clear CD127
low,C D 4
dim phenotype, allowing the
identification of Treg as CD4
+(dim)CD25
+(high)FOXP3
+CD127
low cells
(Figure 2A–C). In contrast Tact, identified as CD4
+CD25
+FOXP3
2
cells, showed lower CD25 expression compared to the FOXP3
+ cells.
In addition most Tact expressed high levels of CD127 and normal
levels of CD4. The expression of CD25
high,C D 4
low, CD127
dim and
FOXP3 were significantly correlated to each other (data not shown),
and hence this combination of markers was used to discriminate
between Tact and Treg populations.
The proportion of CD4
+ T cells classified as Treg in this study
ranged from 1.7 to 10.4% whereas, the proportion of CD4
+ T cells
classified as Tact ranged from 5.3 to 44.8%. A sample from each
of the two age groups is shown in Figure 2B and C. These analyses
revealed that the expression levels of CD25 and CD127 are
comparable on Treg in different age groups whereas minor
changes in the expression of both markers on Tact were observed
in the youngest age group. Specifically, younger people have a
small subset of FOXP3
2 cells which show a CD127
dim CD25
high
phenotype, these were not enumerated as Treg cells.
The percentage of activated but not regulatory T cells
changes with host age
Since the T cell analysis focused on all T cells rather than
schistosome-specific T cells, it was important to determine if the T cell
populations varied with other host attributes. Sex did not affect
proportions of CD4
+CD25
+FOXP3
+ Treg and CD4
+CD25
+FOXP3
2
Tact relative to CD4
+ T cells (statistics presented in Table 1). The
proportion of CD4
+CD25
+FOXP3
+ Treg as percentage of total CD4
+
T cell numbers did not change significantly between age groups as
shown in Figure 3A. Expression of different markers of Tregs in the
different age groups was also compared by analyzing for the proportion
of CD4
+ T cells which were FOXP3
+CD127
dim cells (excluding CD25
as marker; Figure 3B) or the proportion of CD25
high cells (Figure 3C).
Regardless of the marker combination used to identify Treg, no
differences were observed between the two age groups (Figure 3A–C).
However the percentage of activated T cells relative to total CD4
+ T
cells increased significantly with host age (Figure 3D and Table 1). The
latter result meant that in subsequent analyses the confounding effects of
age had to be allowed for before testing for the effects of schistosome
infection intensity on the T cell populations.
The relationship between Treg and infection intensity
varies with host age
The relationship between schistosome infection intensity and
the percentage of regulatory and activated T cells to total CD4
+ T
cells was analyzed, after allowing for the effects of sex and host age
in an analysis of variance. This analysis indicated that the
relationship between Treg proportions and infection intensity
Figure 1. Study population was divided in two age groups. The
8–13 year age group (N=30) infection intensity is rising and peaking,
whereas in the 14+ year age group (N=19) infection intensity is lower.
Dots represent individual values of infection intensity to illustrate
distribution within the age groups and gray line indicates means.
Means were compared by Student’s t-Test and p-value is shown.
doi:10.1371/journal.pone.0016860.g001
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In the young age group where infection was rising, the proportion
of Treg of the total CD4
+ T cell population increased significantly
with increasing infection intensity (Figure 4A). The converse was
true in the older age group where schistosome infection was
declining, here the proportion of Treg declined with increasing
infection intensity (Figure 4B). Grouping the participants by
infection status (non-infected vs. infected as defined by the
presence or absence of schistosome eggs in urine) rather than
infection intensity produced similar results, so that in the younger
age group infected participants had more Treg as proportion of
CD4
+ T cells than non-infected (p=0.05), while in the older age
group infected people had fewer Treg compared to non-infected
(p=0.02; data not shown). In contrast Tact showed no significant
relationship with infection intensity (or infection status) in both age
groups (Figure 4C, D).
Figure 2. Treg and Tact are distinguished by a combination of several markers. (A) PBMC were electronically gated on lymphocyte
population (left panel) followed by gate on total CD4
+ cells (middle panel). CD4
+ cells were analysed for the expression of CD25 and CD127 (right
panel). (A–C) CD25
+FOXP3
+ cells were identified as Treg, whereas CD25
+FOXP3
2 counted as Tact. A dot plot for one individual is shown for group 1
(B) and group 2 (C). Gating on Treg and Tact subsets was verified by further analysis of level of expression of CD25 (B–C, middle panel) and CD127
(B–C, right panel) expressed on Treg (red) and Tact (green). Gray line - isotype control.
doi:10.1371/journal.pone.0016860.g002
Table 1. Influence of host attributes on T cell subsets.
Explanatory variable Dependent variables df F-value p-value
sex Regulatory T cells 1, 47 0.345 0.560
Activated T cells 1, 47 0.000 0.986
age group Regulatory T cells 1, 47 0.105 0.748
Activated T cells 1, 47 14.796 ,0.001
Results from the multivariate analysis of variance determining the effect of host
sex and age on percentages of activated (Tact) and regulatory (Treg) cells. df =
degrees of freedom and tests significant at p,0.05 are highlighted in bold.
doi:10.1371/journal.pone.0016860.t001
Regulatory T Cells in Human Schistosomiasis
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An early paradigm of anti-helminth immune responses was
based upon the Th1/Th2 dichotomy, with resistance to
schistosome infection being associated with Th2 responses [5,6].
Because it is now evident that the Th1/Th2 dichotomy does not
sufficiently explain the balance between susceptibility and
resistance to helminth infections (reviewed in [16]), there is
increasing interest in the ability of regulatory T cells to modulate
effector T cell responses. In mouse models, Treg play important
roles in minimising pathology during schistosome infections
[27,34], and Treg depletion can restore immunity to filarial worm
infections [15]. In human schistosomiasis, initial evidence for the
association of regulatory T cells and infection was obtained by
analysis of CD25
high-expressing cell subsets [36,60], showing a
significant reduction in frequency of these cells following
Figure 3. The proportion of Treg does not differ between age group regardless of markers employed. Dot plots show the fraction of
Treg identified by a combination of different markers: (A) CD25
+FOXP3
+ cells, (B) FOXP3
+CD127
dim cells and (C) CD25
high cells as percentage of CD4
+
T cells in the different age groups. In (D) percentages of CD25
+FOXP3
neg Tact are presented.
doi:10.1371/journal.pone.0016860.g003
Table 2. Relationship between infection intensity and Treg
varies between age groups.
Dependent variables Explanatory variable df F-value p-value
Infection intensity Tact 1, 47 0.638 0.429
Treg 1, 47 2.983 0.092
Tact * age group 1, 47 2.158 0.150
Treg * age group 1, 47 10.031 0.003
Treg * Tact 1, 47 0.185 0.669
Effects of sex and village of residence were allowed for and relation between
infection intensity and T cells subsets was analysed independently and as
function of age group. df = degrees of freedom and tests significant at p,0.05
are highlighted in bold.
doi:10.1371/journal.pone.0016860.t002
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conducted our studies on total populations of Treg and Tact cells
rather than parasite-specific T cells to determine if an association
with schistosome infection could be determined at the T cell
population level. This is in keeping with the paradigm of helminth
infections stimulating regulatory responses which affect responses
to unrelated antigens by affecting effector T cell responses [61].
Therefore our objective was to determine the association of
schistosome infection and these two T cell populations.
In this study we were able to characterise naturally occurring
regulatory T cells in a human helminth infection with a more
comprehensive marker set, namely CD4
+(dim)CD25
+(high)-
FOXP3
+CD127
low cells and analysed the relationship to activated
T cells designated as CD4
+CD25
+FOXP3
2. First we observed
that the proportions of Treg relative to CD4
+ T cells in this
population are slightly higher than those reported in populations
not exposed to schistosomiasis as reported elsewhere [35,45], but
comparable to those reported for Kenyans exposed to S. mansoni
[36] suggesting a relationship between exposure to the helminth
infection and the development of Treg cells. Percentages of Tact
were significantly higher in the older age group compared to the
younger individuals. This is in accordance with data showing that
CD4
+ T cells with effector/memory, which encompass activated T
cells, increase with age, a change which can be already observed
Figure 4. The association of Treg and Tact proportions with infection intensity are presented partitioned by age group. The variation
in infection intensity ((log10 (egg count+1) transformed) was analysed for the potential confounding effects sex and village using ANOVA and
calculated residuals are plotted against the proportion of Treg (A, B) or Tact (C, D; arcsin! transformed) after dividing into two age groups as
indicated. Obtained residuals were used for further used in a regression analysis whose p- and b- values are given.
doi:10.1371/journal.pone.0016860.g004
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to CD4
+ T cells did not differ significantly between the two age
groups.
The most striking finding of this study was that the correlation
between Treg proportion and infection intensity of S. haematobium
differed significantly between the two age groups. After controlling
for the confounding factors of age (and thus age related biological
processes) we demonstrated that Treg as percentages of total CD4
+
T cells were correlated with infection intensity, being significantly
positive in the younger age group where infection was rising and
peaking. In contrast the converse was true in the older age group
where higher infection intensity was associated with lower Treg
numbers. However there was no significant association between
the infection intensity and Tact. The consequence is an increase of
the ratio of regulatory to activated T cells with infection intensity
in younger people (dictated by Treg) which may suggest a down-
regulation of effector responses, but also may protect against
immunopathology [27,33,63]. In contrast the correlation between
proportions of regulatory T cells and level of infection turned
negative in the older age group in whom infection levels were
declining, suggesting that older individual carrying infection might
be more prone to developing the characteristic immunopathology
of chronic schistosomiasis.
However the relationship between different levels of Treg
relative to infection intensity and the development immunopa-
thology remains to be established. Furthermore detailed studies of
parasite-specific T cell and functional characterization will clarify
the nature and development of responses associated with resistance
to human schistosome infections.
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